Get the Right Particle Count

Ask for at Least 350,000 Particles in Every Unit Dose

A quality V/Q scan depends on the
quality and reliability of DRAXIMAGE® MAA—
from start to finish

A quality V/Q scan depends on the quality and reliability of DRAXIMAGE® MAA— from start to finish

At Jubilant DraxImage, we are committed to providing healthcare professionals reliable, high-quality macroaggregated albumin (MAA) to enable the accurate diagnosis of patients suspected of having pulmonary embolism. To ensure a quality V/Q scan from start to finish, it’s important to confirm that every unit dose contains at least the recommended 350,000 particle count.

Radiopharmacists and nuclear medicine technologists who prepare unit doses of DRAXIMAGE® MAA should be aware of the suggested number of particles as prescribed in the FDA- and Health Canada-approved package inserts.1 The 350,000 particle count also complies with the Society of Nuclear Medicine and Molecular Imaging and American College of Radiology guidelines.2,3

Our foremost concern is the quality of the V/Q image produced using DRAXIMAGE MAA. Preparing doses with the correct number of particles affects how uniformly particles are distributed across the perfused pulmonary vascular bed and has been shown to yield good to excellent images.4

If you have any questions or would like assistance in ensuring the compliance of your radiopharmacy, contact your Regional Sales Manager or Customer Service at 1-888-633-5343.

DRAXIMAGE® MAA350k particles

References:

  1. DRAXIMAGE® MAA, Kit for Preparation of Technetium Tc99m Albumin Aggregated Injection [Package Insert]. Kirkland, Québec, H9H 4J4, Canada: Jubilant DraxImage, Inc.; 2011.
  2. Parker JA, Coleman RE, Grady E, et al. SNM practice guideline for lung scintigraphy 4.0. J Nucl Med Technol. 2012;40(1):57–65.
  3. American College of Radiology. ACR–SPR–STR practice parameter for the performance of pulmonary scintigraphy. Resolution 30. Revised 2014. Available at: www.acr.org/~/media/860d4274393a477daa0d6acf663c9ed8.pdf. Accessed on October 15, 2015.
  4. Data on file, Jubilant DraxImage, Inc.

DISCLAIMER:

This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. For full Prescribing Information including indications, contraindications, warnings, precautions and adverse events, please see the appropriate product labeling.